Skip to main content
Clinical Trials/NCT03249818
NCT03249818
Completed
Not Applicable

Feasibility Study of Head and Intraocular Trauma Test (HITT) Device for Potential Detection of Brain Dysfunction

Rebiscan, Inc.1 site in 1 country7 target enrollmentAugust 22, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Brain Injuries, Traumatic
Sponsor
Rebiscan, Inc.
Enrollment
7
Locations
1
Primary Endpoint
TBI detection
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

The purpose of this research study is to collect data from the eyes of traumatic brain injury (TBI) patients. Patients will look at a green target that will measure the fixation of the eye for 30 seconds. In that 30 seconds, the location of the green target will change and the participant is to track, with their eyes, the light as best they can. The device will measure how well fixation was maintained and the speed of the saccadic movements of the eye. Data will then be used to determine whether there is correlation between these measures and known TBI.

Registry
clinicaltrials.gov
Start Date
August 22, 2017
End Date
February 28, 2018
Last Updated
7 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Documented/ verified mild TBI
  • Mild traumatic brain injury will be defined as Glasgow Coma Scale (GCS) of ≥13 at time of study enrollment
  • Injury occurred \< 24 hours ago
  • Positive acute brain CT for clinical care
  • Visual acuity/ hearing adequate for testing
  • Fluency in English or Spanish
  • Ability to provide informed consent
  • Enrolled in TRACK-TBI (IRB #: 825503)

Exclusion Criteria

  • Catastrophic polytrauma that would interfere with follow-up and outcome assessment
  • Prisoners or patients in custody
  • Pregnancy in female subjects
  • Patients on psychiatric hold (e.g. 5150, 5250)
  • Major debilitating baseline mental health disorders (e.g. schizophrenia or bipolar disorder) that would interfere with follow-up and the validity of outcome assessment
  • Major debilitating neurological disease (e.g. stroke, dementia, tumor) impairing baseline awareness, cognition, or validity of follow-up and outcome assessment
  • Significant history of pre-existing conditions that would interfere with follow-up and outcome assessment (e.g. substance abuse, alcoholism, HIV/AIDS, major transmittable diseases that may interfere with consent, end-stage cancers, learning disabilities, developmental disorders)
  • Low likelihood of follow-up (e.g. participant or family indicating low interest, homelessness or lack of reliable contacts)
  • Penetrating TBI
  • Spinal cord injury with ASIA (American Spinal Injury Assoc.) score of C or worse

Outcomes

Primary Outcomes

TBI detection

Time Frame: 1 day

Patients who have diagnosed TBI and are admitted to the hospital for treatment will have their eyes scanned to identify whether the HITT device can accurately identify patients with TBI

Secondary Outcomes

  • TBI monitor(14 days)

Study Sites (1)

Loading locations...

Similar Trials